Verified email-pattern data for Revopsis Therapeutics is currently limited. You can still use the company insights and contact sections below.
RevOpsis Therapeutics is a next-generation biopharmaceutical company that is trailblazing a new era in multispecific antibody discovery and development to unlock transformative treatments for complex disease.
Our process is simple. Our proprietary Rev-Mod Platform uses a modular plug-and-play system to streamline drug discovery and development. The Rev-Mod Platform features a library of ~30 billion fully human and fully compatible antibody components that are ready to be assembled into functional Multi-Mod biologics. Using this platform, we can select and integrate multiple antibody components into a single, multispecific therapeutic molecule that binds targets implicated in known, clinically validated disease pathways.
Our lead asset from this platform, RO-104, is a first-in-class trispecific biologic. RO-104 targets 3 clinically validated pathways that are implicated in retinal vascular diseases, such as neovascular age-related macular degeneration (nAMD). Whereas current anti-VEGF therapies used to treat nAMD predominantly target only the VEGF-A pathway, RO-104 builds on a body of literature that suggests that combining the targeting of VEGF-A, VEGF-C, and Ang-2 can improve patients’ therapeutic gains and extend treatment durability. RO-104 has the potential to offer these benefits with a single therapeutic molecule, as preclinical studies indicate high affinity to all 3 targets, efficacy in a choroidal neovascularization model, and ideal drug-like properties.
Company Details
- Employees
- 4
- Founded
- -
- Industry
- Biotechnology Research
- Website
- http://www.revopsis.com
- Keywords
- Specialist jobs.
Revopsis Therapeutics Questions
RevOpsis Therapeutics's website is http://www.revopsis.com
RevOpsis Therapeutics's LinkedIn profile is https://www.linkedin.com/company/revopsis
RevOpsis Therapeutics has
4 employees.
View email and phone details for 4
employees at RevOpsis Therapeutics.
RevOpsis Therapeutics's industry is
Biotechnology Research
RevOpsis Therapeutics's top competitors are
Jlsa2 Therapeutics, Inc.,
Outlook Therapeutics, Inc.,
Asimov,
Kemwell Biopharma,
Protagonist Therapeutics,
Annexin Pharmaceuticals Ab (Publ),
Onl Therapeutics,
Opthea,
Torch Therapeutics, Inc.,
Ocular Therapeutix, Inc..
RevOpsis Therapeutics's categories are Biotechnology Research
RevOpsis Therapeutics's founding year is 2022
Explore related pages
Related company profiles:
Top RevOpsis Therapeutics Employees
-
Jessi Prentice
Ophthalmology Np
Greater St. Louis, United States2bausch.com, springfieldclinic.com
Free Chrome Extension
Find emails, phones & company data instantly
Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Aero Online
Your AI prospecting assistant
Select data to include:
Total price:
$0.00
0 records × $0.02 per record
How It Works
Get a Free Account
Sign up for a free account. No credit card required. Up to 10 free credits.
Search the #1 Contact Database
Get contact details of over 750M+ profiles across 60M companies – all with industry-leading accuracy. Sales Navigator and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.